Tag Archive | ovarian cancer
New drug may fight ovarian cancer
A new drug has offered fresh hope to ovarian cancer sufferers.
Drinking tea ‘cuts ovarian cancer risk’
Drinking tea can decrease your risk of developing ovarian cancer, according to a new study.
Hormone may predict favourable outcome for ovarian cancer
Nov 16 : A recent study has found that Kisspeptin and its G-protein group receptor GPR54 are capable of predicting a favourable outcome in woman with ovarian carcinoma.
Low- fat diet may reduce ovarian cancer risk
Oct 10 (ANI): According to a clinical trial conducted by Women’s Health Initiative (WHI), a low fat diet can reduce the risk of ovarian cancer in healthy postmenopausal women.
Breast cancer drug may offer hope for treating ovarian cancer
June 15 : Researchers from Edinburgh University have revealed that drug letrozole, which is used to treat breast cancer, can increase the life span of people suffering from Ovarian cancer by three years.
Discovery of protein may help treat breast, ovarian cancers
Ottawa, March 21 Canadian researchers have found a key protein to treat metastatic breast and ovarian cancers, making “smart” therapies possible for these diseases.
Obesity affects ovarian-cancer survival
Whether a U.S. woman is obese may likely affect her outcome if she has been diagnosed with ovarian cancer, according to a Cedars-Sinai Medical Center study.
Nanobac Life Sciences Announces Publication Linking Nanobacterial Infection and Calcified Ovarian Cancer
Nanobac Life Sciences, Inc. , announced today the publication of a study entitled “Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization” in the peer reviewed journal Histopathology (2004) 45, 633-637.
Nanobac’s Nanobacteria-specific 8D10 antibody and nanobacterial culture technique were used in these experiments.
Gene Expression Profiling Helps In Ovarian Cancer Prognosis
The identification of a gene expression profile using microarray technology may help clinicians better determine the prognosis of patients with advanced stage ovarian cancer and may eventually help provide targeted therapies for this hard-to-treat disease, according to a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC).